Stimulation of the human spermatozoal fertilizing ability by dibutyryl 3',5'-CAMP and theophylline in vitro

Arch Androl. 1983 Aug;11(1):19-23. doi: 10.3109/01485018308987454.

Abstract

The stimulation of the human spermatozoal fertilizing ability by dibutyryl 3',5'-CAMP (diCAMP) and theophylline in suspected fertile and subfertile semen samples was demonstrated with the zona-free hamster ova penetration test. The penetration rates for the untreated (control) fertile and subfertile samples were 30% and 17%, respectively. DiCAMP increased the penetration rates to 54% and 37% (with 5 mM diCAMP) and to 46% and 36% (with 10 mM diCAMP) in the fertile and subfertile samples, respectively; theophylline increased the penetration rates to 56% and 35% (with 10 mM theophylline) and to 49% and 42% (with 20 mM theophylline) in the fertile and subfertile samples, respectively. These results indicate that diCAMP and theophylline can affect the fertilizing ability of human spermatozoa in vitro.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bucladesine / pharmacology*
  • Cricetinae
  • Female
  • Humans
  • Infertility, Male / physiopathology
  • Male
  • Sperm-Ovum Interactions / drug effects
  • Spermatozoa / drug effects*
  • Theophylline / pharmacology*

Substances

  • Bucladesine
  • Theophylline